arrow_rightarrow_righticon_excelicon_pficon_ppticon_wordmagnifier

Program ICLB/ESGBOR symposium

Monday 06 Sep

The 2021 virtual ICLB/ESGBOR symposium on Lyme borreliosis: from ecology to prevention

17:00

Introduction by the chairs

Board ESGBOR Board - Volker Fingerle, Anna Henningsson, Mateusz Markowicz & ILCB ICLB2022 chairs - Joppe Hovius, Hein Sprong

17:05

Key aspects of the ecology of Lyme and other tick-borne diseases

Felicia Keesing (Bard College, Annandale, NY, USA)

Felicia Keesing is an ecologist who studies how changes to the environment affect the transmission of infectious diseases, particularly tick-borne diseases such as Lyme disease.

161104_caryinstitute_reiss-28

17:30

Q&A

17:40

The new IDSA guideline, a European perspective

Franc Strle (University Medical Center Ljubljana, Ljubljana, Slovenia)

18:05

Q&A

18:15

Break & musical Intermezzo

Info musical Intermezzo - Passacaglia van Händel-Halvorsen en Duo’s van Reinhold Glière

Laura Oomens & Anastasia Feruleva

18:25

Development of a multivalent OspA based Lyme vaccine: Update on Phase 2 clinical studies in healthy adults

Nicole Bezay (Valneva, Saint-Herblain, France)

Nicole Bézay, PhD, is Director Clinical Strategy at Valneva, a speciality vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases. She is the clinical lead for a new multivalent Lyme borreliosis vaccine candidate, which is currently in clinical Phase 2 testing.

Foto_Bezay

18:50

Q&A

19:00

Closure